Renew Biotechnologies has been honored with the 'Biomarker Discovery Platform of the Year' title for its innovative NeuroLens™ platform, advancing neurodegenerative disease research.

Renew Biotechnologies and Mayo Clinic join forces to assess NeuroLens® for multiple sclerosis, aiming for improved patient care through advanced molecular insights.

Renew Biotechnologies has published groundbreaking research in Frontiers in Neurology, highlighting new blood biomarkers for neurodegeneration.

Renew Labs, a leader in clinical laboratory services, has recently received accreditation from the College of American Pathologists, enhancing its commitment to quality.

Renew Biotechnologies has officially merged Wasatch BioLabs and Resonant into a single brand, enhancing their diagnostic capabilities and research infrastructure.

Valinor and Renew Biotechnologies have partnered to create the largest clinical multi-omics dataset aimed at advancing neurological disease research and therapies.

Renew Biotechnologies has revealed its role in the new NOA Guide by Path Fertility, enhancing diagnostic clarity for men with infertility issues.